Articles dans des revues avec comité de lecture (100)
61.
Nielsen, T. O., Poulsen, S. S., Journé, F., Ghanem, G. E., & Sorensen, B. S. (2014). HER4 and its cytoplasmic isoforms are associated with progression-free survival of malignant melanoma. Melanoma research, 24(1), 88-91. doi:10.1097/CMR.000000000000004062.
Krayem, M., Journé, F., Wiedig, M., Morandini, R., Sales, F., Awada, A., & Ghanem, G. E. (2014). Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of (WT)BRAF/(WT)NRAS melanoma cells to vemurafenib. European journal of cancer. doi:10.1016/j.ejca.2014.01.02163.
Aftimos, P., Wiedig, M., Langouo Fontsa, M., Awada, A., Ghanem, G. E., & Journé, F. (2013). Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: a rationale to combine targeted drugs based on protein expression inhibition profiles. International journal of oncology, 43(3), 919-926. doi:10.3892/ijo.2013.200864.
Kindt, N., Laurent, G., Nonclercq, D., Journé, F., Ghanem, G. E., Duvillier, H., Gabius, H.-J., Lechien, J., & Saussez, S. (2013). Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells. International journal of oncology, 43(1), 185-193. doi:10.3892/ijo.2013.194465.
El Hajj, P., Journé, F., Wiedig, M., Laïos, I., Salès, F., Galibert, M.-D., Van Kempen, L. C., Spatz, A., Badran, B., Larsimont, D., Awada, A., & Ghanem, G. E. (2013). Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients. British Journal of Cancer, 108(8), 1641-1647. doi:10.1038/bjc.2013.11566.
Herraiz, C., Journé, F., Ghanem, G. E., Jimenez-Cervantes Frigo, C., & Garcia-Borron, J. C. (2012). Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells. International journal of biochemistry & cell biology, 44(12), 2244-2252. doi:10.1016/j.biocel.2012.09.00867.
Desmedt, C., Majjaj, S., Kheddoumi, N., Singhal, S. K., Haibe-Kains, B., El Ouriaghli, F., Chaboteaux, C., Michiels, S., Lallemand, F., Journé, F., Duvillier, H., Loi, S., Quackenbush, J., Dekoninck, S., Blanpain, C., Lagneaux, L., Houhou, N., Delorenzi, M., Larsimont, D., Piccart-Gebhart, M., & Sotiriou, C. (2012). Characterization and Clinical Evaluation of CD10+ Stroma Cells in the Breast Cancer Microenvironment. Clinical cancer research, 18(4), 1004-1014. doi:10.1158/1078-0432.CCR-11-038368.
Id Boufker, H., Lagneaux, L., Fayyad Kazan, H., Badran, B., Najar, M., Wiedig, M., Ghanem, G. E., Laurent, G., Body, J.-J., & Journé, F. (2011). Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts. Bone, 49(6), 1219-1231. doi:10.1016/j.bone.2011.08.01369.
Journé, F., Id Boufker, H., van Kempen, L., Galibert, M.-D., Wiedig, M., Sales, F., Theunis, A., Nonclercq, D., Frau, A., Laurent, G., Awada, A., & Ghanem, G. E. (2011). TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome. British Journal of Cancer, 105(11), 1726-1732. doi:10.1038/bjc.2011.45171.
Herraiz, C., Journé, F., Abdel-Malek, Z., Ghanem, G. E., Jimenez-Cervantes Frigo, C., & Garcia-Borron, J. C. (2011). Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. Molecular endocrinology, 25(1), 138-156. doi:10.1210/me.2010-021772.
Id Boufker, H., Lagneaux, L., Najar, M., Piccart-Gebhart, M., Ghanem, G. E., Body, J.-J., & Journé, F. (2010). The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts. BMC cancer, 10, 298. doi:10.1186/1471-2407-10-298